MedTrace Logo

Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer

NCT02079623 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2020-01-10

No results posted yet for this study

Summary

The aim for this study is to implement electroporation therapy (NanoKnife) treatment for patients with locally advanced pancreatic cancer. Electroporation therapy (NanoKnife) will be given in addition to standard chemotherapy.

Conditions

Interventions

PROCEDURE

Electroporation/ Nano knife treatment

DEVICE

NanoKnife

Sponsors & Collaborators

  • Uppsala University Hospital

    collaborator OTHER

  • Aalborg University Hospital

    lead OTHER

Principal Investigators

  • Ole Thorlacius-Ussing, Prof., cons., dr. med · Department of Gastroinstestinal Surgery, Aalborg University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2019-05-01
Completion
2019-05-01
FDA Device
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02079623 on ClinicalTrials.gov